治疗性血交换用于IgA多发性骨髓瘤中的超粘性综合征
Nalan Yurtsever1, Thomas C Binns1, Jeanne E Hendrickson2
1Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, US.
Laboratory medicine
|July 22, 2024
概括
这项研究报告了一种罕见的免疫球蛋白A (IgA) 髓瘤引起的高粘度综合征 (HVS) 病例. 治疗性血交换有效降低了IgA水平和粘度,改善了患者的症状.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 超粘度综合征 (HVS) 呈现出血液粘度的增加,通常与诸如高球蛋白血症等疾病有关.
- IgA多发性骨髓瘤是HVS的一个不常见的原因.
- 治疗性血交换 (TPE) 对IgA去除的疗效尚未得到充分证实.
研究的目的:
- 为了描述IgA骨髓瘤的第二次HVS病例.
- 评估TPE在控制IgA相关的HVS方面的有效性.
主要方法:
- 一名患有IgA骨髓瘤,呈现HVS的患者接受了TPE治疗.
- 进行了IgA水平和血液粘度的连续测量.
主要成果:
- 进行了两次TPE治疗.
- 患者经历了症状的改善.
- 在TPE后观察到IgA水平和血液粘度的显著降低.
结论:
- TPE可以作为IgA髓瘤引起的HVS的有效治疗方法.
- 这一案例凸显了TPE在治疗罕见多发性骨髓瘤的潜在益处.
相关概念视频
Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Nephrotic Syndrome II : Assessment and Medical Management
409
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
409
Nephrotic Syndrome III : Nursing Management
549
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
549
Hemodialysis II: Procedure and Complications
2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K


